Ambergen
Pre-clinicalNext Generation Spatial Biology: AmberGen’s patented Miralys™ Photocleavable Mass-Tag Imaging Significantly Boosts the Capability of Mass Spectrometry Imaging
Founded
2000
Focus
ProteomicsDiagnostics
About
Next Generation Spatial Biology: AmberGen’s patented Miralys™ Photocleavable Mass-Tag Imaging Significantly Boosts the Capability of Mass Spectrometry Imaging
Funding History
98Total raised: $107.7M
Grant$1.1MNIAAug 2, 2023
Grant$979KNIAIDJul 26, 2023
Grant$910KNIMHJul 24, 2023
Series A$45MRA Capital ManagementNov 15, 2022
Company Info
TypePrivate
Founded2000
LocationWaltham, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile